Total Payments
$4,679
2024 Payments
$895.66
Companies
31
Transactions
249
Medicare Patients
116
Medicare Billing
$4,914
Payment Breakdown by Category
Food & Beverage$4,414 (94.3%)
Other$250.00 (5.3%)
Education$15.10 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,414 | 246 | 94.3% |
| Honoraria | $250.00 | 2 | 5.3% |
| Education | $15.10 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $682.24 | 52 | $0 (2024) |
| Optinose US, Inc. | $619.75 | 37 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $570.77 | 30 | $0 (2024) |
| CSL Behring | $413.02 | 23 | $0 (2024) |
| GENZYME CORPORATION | $368.97 | 17 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $292.39 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $280.01 | 12 | $0 (2024) |
| Genentech USA, Inc. | $174.67 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $165.16 | 8 | $0 (2024) |
| ABBVIE INC. | $146.84 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $895.66 | 47 | CSL Behring ($213.55) |
| 2023 | $1,439 | 70 | GlaxoSmithKline, LLC. ($273.16) |
| 2022 | $1,157 | 65 | OptiNose US, Inc. ($230.09) |
| 2021 | $1,187 | 67 | AstraZeneca Pharmaceuticals LP ($178.66) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Immunology | ||||||
| 12/05/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/04/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/04/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/31/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Immunology | ||||||
| 09/19/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/03/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: Immunology | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/01/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Respiratory | ||||||
| 06/03/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 6 | 116 | 226 | $32,989 | $4,914 |
Total Patients
116
Total Services
226
Medicare Billing
$4,914
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 37 | $14,611 | $2,339 | 16.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 36 | $9,623 | $1,375 | 14.3% |
| 94375 | Diagnostic testing in a pulmonary function lab | Office | 2020 | 20 | 27 | $3,564 | $512.29 | 14.4% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 20 | 72 | $2,772 | $435.78 | 15.7% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2020 | 16 | 23 | $1,898 | $214.68 | 11.3% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2020 | 14 | 31 | $521.73 | $37.99 | 7.3% |
About Caitlyn Fox, NP
Caitlyn Fox, NP is a Family healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1487141446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Caitlyn Fox, NP has received a total of $4,679 in payments from pharmaceutical and medical device companies, with $895.66 received in 2024. These payments were reported across 249 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,414).
As a Medicare-enrolled provider, Fox has provided services to 116 Medicare beneficiaries, totaling 226 services with total Medicare billing of $4,914. Data is available for 1 year (2020–2020), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Springfield, IL
- Active Since 04/16/2018
- Last Updated 09/10/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1487141446
Products in Payments
- Xhance (Drug) $619.75
- DUPIXENT (Biological) $550.15
- TRELEGY ELLIPTA (Drug) $491.85
- Hizentra (Biological) $314.53
- PALFORZIA (Biological) $292.39
- CUVITRU (Biological) $206.95
- FASENRA (Biological) $198.72
- NUCALA (Biological) $174.70
- Xolair (Biological) $164.64
- GLASSIA (Biological) $113.60
- Haegarda (Biological) $98.49
- AUVI-Q (Drug) $82.80
- RINVOQ (Biological) $78.29
- Yupelri (Drug) $76.87
- TEZSPIRE (Biological) $76.05
- Prolastin-C Liquid (Biological) $74.56
- TAKHZYRO (Biological) $71.17
- (8874) inCourage (Device) $62.34
- Xembify (Biological) $55.70
- SPIRIVA RESPIMAT (Drug) $52.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Springfield
Mrs. Erin Duvall, Aprn, Fnp-C, Pmhnp-B, APRN, FNP-C, PMHNP-B
Family — Payments: $207,898
Family $207,898
Laura Hediger, Fnp, FNP
Family — Payments: $62,482
Family $62,482
Jenna Pelc, Np, NP
Family — Payments: $50,048
Family $50,048
Emily Wouk, Msn, Fpmhnp, Fnp, MSN, FPMHNP, FNP
Family — Payments: $41,104
Family $41,104
Mrs. Kristie Harrington, Fnp-Bc, FNP-BC
Family — Payments: $17,270
Family $17,270
Karen Smith, Crnp, CRNP
Family — Payments: $13,950
Family $13,950